Showing results (541-550 of 2,736) with videos related to
Sort By:
Pageof 274
Expert Review of Neurotherapeutics|September 24, 2013
Current status of safinamide for the drug portfolio of Parkinson's disease therapyThomas MüllerExpert Review of Neurotherapeutics|October 15, 2013
The circadian rhythm in adult attention-deficit/hyperactivity disorder: current state of affairsJ J Sandra Kooij, Denise BijlengaExpert Review of Neurotherapeutics|October 15, 2013
The comorbidity of ADHD and autism spectrum disorderKevin M Antshel, Yanli Zhang-James, Stephen V FaraoneExpert Review of Neurotherapeutics|June 7, 2013
Fingolimod for the treatment of relapsing multiple sclerosisBarry A SingerExpert Review of Neurotherapeutics|June 7, 2013
Novel frontiers in epilepsy treatments: preventing epileptogenesis by targeting inflammationRaimondo D'Ambrosio, Clifford L Eastman, Cinzia Fattore, et al.Expert Review of Neurotherapeutics|June 7, 2013
Network modeling to identify new mechanisms and therapeutic targets for Parkinson's diseaseLinda MacArthur, Habtom Ressom, Salim Shah, et al.Expert Review of Neurotherapeutics|June 7, 2013
Detoxification and antioxidative therapy for levodopa-induced neurodegeneration in Parkinson's diseaseThomas MüllerExpert Review of Neurotherapeutics|June 7, 2013
Continuous dopaminergic delivery to minimize motor complications in Parkinson's diseaseBrenton A Wright, Cheryl H WatersExpert Review of Neurotherapeutics|April 3, 2013
Current and future directions for Phase II trials in high-grade gliomaBrian M Alexander, Eudocia Q Lee, David A Reardon, et al.Expert Review of Neurotherapeutics|April 30, 2013
Novel findings in pain processing pathways: implications for miRNAs as future therapeutic targetsKatharina L Kynast, Otto Q Russe, Gerd Geisslinger, et al.Pageof 274